Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chemocentryx Inc. (DE:2CX)
FRANKFURT:2CX
ChemoCentryx (2CX) Financial Statements
0 Followers
ChemoCentryx Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 11.76M | $ 5.46M | $ 2.29M | $ 17.69M | $ 1.70M |
| Gross Profit | $ 10.96M | $ 5.25M | $ 1.99M | - | - |
| EBIT | $ -31.07M | $ -38.01M | $ -39.88M | $ -21.64M | $ -38.51M |
| EBITDA | $ -30.04M | $ -36.99M | $ -38.87M | $ -20.64M | $ -37.51M |
| Net Income Common Stockholders | $ -31.65M | $ -38.61M | $ -40.53M | $ -22.31M | $ -39.21M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 328.62M | $ 340.60M | $ 264.49M | $ 269.43M | $ 312.60M |
| Total Assets | $ 419.39M | $ 440.45M | $ 425.65M | $ 454.85M | $ 467.67M |
| Total Debt | $ 72.00M | $ 72.66M | $ 73.28M | $ 72.95M | $ 71.70M |
| Net Debt | $ -256.61M | $ -267.94M | $ -191.22M | $ -196.47M | $ -240.90M |
| Total Liabilities | $ 182.86M | $ 181.73M | $ 139.53M | $ 138.95M | $ 137.40M |
| Stockholders Equity | $ 236.53M | $ 258.72M | $ 286.12M | $ 315.89M | $ 330.27M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -26.53M | $ 8.61M | $ -11.38M | $ -29.67M | $ -21.15M |
| Operating Cash Flow | $ -26.13M | $ 8.83M | $ -10.89M | $ -25.32M | $ -17.85M |
| Investing Cash Flow | $ 28.08M | $ -21.34M | $ -36.54M | $ 42.33M | $ 25.77M |
| Financing Cash Flow | $ 1.86M | $ 3.10M | $ 3.68M | $ -489.00K | $ 742.00K |
ChemoCentryx Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.